Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 20, 2025 07:00 ET | Source: Beckley Psytech

Beckley Psytech announces positive topline data from Part 2 of its Phase IIa study of BPL-003 (intranasal 5-MeO-DMT benzoate) in combination with SSRIs for treatment resistant depression

Positive results show that a single dose of BPL-003, administered adjunctively to SSRIs, produced a rapid and long-lasting antidepressant effect for up to three months after dosing.BPL-003 was...
May 15, 2019 13:27 ET | Source: Reports And Data

Anxiety Disorder and Depression Treatment Market To Reach USD 18.90 Billion By 2026 | Reports And Data

The rise in the graying population and minimal side effects associated with the treatment are some of the factors boosting the market for Anxiety Disorder and Depression Treatment. Market Size – USD...